Fig. 1From: Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective studyFlow diagram of this study. UTUC upper-tract urothelial carcinoma, EPI epirubicin, GEM gemcitabine, HCPT hydroxycamptothecinBack to article page